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Background: Medicines to treat common colds (CC) and upper respiratory tract infections (URTI) are widely used
among children, but there are only few data about treatments actually applied for these diseases. In the present
study we analyze the prevalence and correlations of self-medicated and prescribed drug use for the treatment of
CCs and URTIs among children and adolescents in Germany.
Methods: Medicine use during the week preceding the interview was recorded among 17,450 children (0–17
years) who participated in the drug interview of the 2003–2006 German Health Interview and Examination Survey
for Children and Adolescents (KiGGS). The definition of CCs and URTIs in the present study included the WHO-ICD-10
codes J00, J01.0, J01.9, J02.0, J02.9, J03.0, J03.9, J04.0, J06.8, J06.9, J11.1, J11.8, R05 and R07.0. Using the complex sample
method, the prevalence and associated socio-demographic factors of self-medication, prescribed medicines and
antibiotics were defined.
Results: 13.8% of the participating girls and boys use drugs to treat a CC or an URTI. About 50% of this group
use prescribed medications. Among the users of prescribed medication, 11.5% use antibiotics for the treatment
of these diseases. Looking at all prescribed medicines we find associations with younger age, immigration
background, and lower social status. Antibiotic use in particular is associated with female sex, higher age,
residency in the former East Germany and immigration background.
Conclusions: The use of medicines to treat CCs or URTIs is widespread among children and adolescents in
Germany. Thus, longitudinal studies should investigate the risks associated with this drug use. Differences in
socio-demographic variables regarding exposure to antibiotic use indicate that there could be an implausible
prescribing behavior among physicians in Germany.
Keywords: Common cold, Upper respiratory tract infection, Cough & cold medicines, Pharmacotherapy,
Antibiotics, Children, KiGGSBackground
Common colds (CCs) and other upper respiratory tract
infections (URTIs) are usually self-limiting conditions
with a high prevalence worldwide. Earlier analyses of the
German Health Interview and Examination Survey for
Children and Adolescents (KiGGS) indicate that the 1-
year-average-prevalence of CCs among children and adoles-
cents amounts to 88.5%, with the highest prevalence among* Correspondence: knopfh@rki.de
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unless otherwise stated.children aged 3 to 6 years - almost 94% [1]. According to
the literature, an average child undergoes a minimum of 4
to 8 URTIs per year [2-4]. Due to missing or low immunity
in the first years of life, children are particularly vulnerable
to viral infections [5].
Medicines against CCs and its symptoms are widely
marketed, e.g. cough medicines, nasal decongestants,
throat medicines, but also vitamins and herbal or
homeopathic medicines. Data of the statutory health in-
surance document that 9 of the 20 most often prescribed
drugs for children and adolescents belong to cough&-
cold medicines (CCMs) [6]. Additionally, many of thesed. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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ing children’s and adolescents’ use of medications to
treat CCs and URTIs throws light on the prevalence and
related factors of drug use and is an essential step for
understanding issues concerning their safety. Data from
health insurances and sales figures are not able to com-
pletely provide this transparency as they do not neces-
sarily correspond to the actual medication usage. In the
USA, serious adverse events and even some deaths are
associated with the use of OTC CCMs [8,9]. About 7%
of all pediatric prescriptions for the respiratory tract sys-
tem are not officially licensed for use in children, which
means that they have never been tested rigorously for
pediatric safety and efficacy [10]. Earlier analyses of
KiGGS suggest that about 30% of the medicines are used
off-label in terms of under-dosing, over-dosing, untested
indication, or age [11].
Antibiotics are usually not indicated for viral infec-
tions such as uncomplicated URTIs or CCs. Antibiotics
do not lead to an improvement of CC and URTI symp-
toms, but they yield potential side effects [12,13]. Never-
theless, their use is common: Data from the statutory
health insurance show that an URTI is the main reason
for an antibiotic prescription. The data also indicate that
antibiotic use is highest among children aged 0 to 4 years
[14]. High and unnecessary antibiotic consumption is
not only a problem for the individual but for the whole
population, as this is one of the main reasons for anti-
biotic resistances [15].
However, national representative data regarding the
pharmacoepidemiology of CCs and URTIs in the child
population of Germany are lacking. By analyzing data
of the KiGGS survey we attempt to fill this knowledge
gap. We describe prevalence rates, investigate socio-
demographic characteristics and analyze factors associ-
ated with the use of CC and URTI medicines. The
analyses are differentiated into the use of overall
CCMs, prescribed CCMs, self-medicated CCMs, and
antibiotic use.
Methods
KiGGS, a nationwide representative Health Interview
and Examination Survey for children and adolescents,
was conducted by the Robert Koch Institute between
May 2003 and May 2006. The target population com-
prised all non-institutionalized residents of Germany be-
tween 0 and 17 years of age. Therefore, children and
adolescents with a foreign nationality were also included.
A detailed description of the methods of KiGGS have
been published elsewhere [16]. Briefly, two-stage sam-
pling procedures were applied. In the first stage 167 mu-
nicipalities were drawn. This sample was representative
for municipality sizes and structures in Germany. In the
second stage, samples of children and adolescents agedbetween 0 and 17 years were drawn randomly from the
corresponding local population registries. In total,
17,641 participants were included in the survey which
equated to a response rate of 66.6%. Nonresponse
analysis showed only little differences in socio-demographic
and health-related variables between responders and non-
responders. The survey was approved by the Ethics
Committee of the Virchow Hospital, Humboldt University
Berlin and federal data-protection officials. The children’s
parents/guardians and/or children aged 14 years or older
were informed about all aspects of the survey and they
submitted a written consent [17].
Standardized, age-specified self-administered question-
naires filled out by parents/guardians and children aged
11 years or older were used to collect socio-demographic
data, family background and health-related issues. The chil-
dren’s age was categorized in 5 age groups: 0–2, 3–6, 7–10,
11–13, and 14–17 years. Children with immigration
background were defined as those who had no German na-
tionality themselves or whose parents had no German na-
tionality. In order to calculate the socio-economic status
according to Winkler, the parents’ education, professional
classification and household net income were inquired [16].
Medicine use was investigated in a standardized computer-
assisted face-to-face-interview by a physician. Information
on medicine use was collected by asking the parents and
the children themselves. The participants were asked to
bring all of the original packages of medicines used in the
last 7 days to the interview. Drug use was assessed by the
following question: “Has your child taken any medicines in
the last 7 days? Please also mention any ointments, linea-
ments, contraceptive pills, vitamin and mineral supple-
ments, medicinal teas, herbal medicines and homeopathic
medicines.” For all of the used drugs further information
was collected, such as the form of administration, frequency
of intake, origin (‘prescribed by a doctor’, ‘prescribed by a
non-medical practitioner’, ‘bought over the counter’, ‘ob-
tained from other sources’), duration of use, improvement
of the condition(s) treated, and degree of tolerability. In
addition, up to two conditions for which the medication
was taken were registered. The reported medicines were
classified according to the Anatomical Therapeutic Chem-
ical (ATC) codes and the conditions treated according to
the WHO International Classification of Diseases-10 codes
(WHO ICD-10 codes) [18]. To evaluate the medication
used for CCs or URTIs we included the following condi-
tions (WHO-ICD-10 codes in brackets): CC (J00), acute
sinusitis (J01.0, J01.9), acute pharyngitis (J02.0, J02.9), acute
tonsillitis (J03.0, J03.9), acute laryngitis (J04.0), acute re-
spiratory tract infections (J06.8, J06.9), influenza (J11.1,
J11.8), cough (R05) and sore throat (R07.0).
All statistical analyses were performed using SPSS statis-
tical software 18.0. The analyses were performed with a
weighting factor to adjust for deviations in demographic
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Germany, level of urbanity) in comparison to the national
child population. Descriptive statistics were used to es-
timate the prevalence of medication use to treat CCs
or URTIs according to sex, age, region of residence,
immigration background, and social status. Prevalence
of self-medication, prescribed medicines and antibiotic
use were estimated among those children who used
drugs to treat CCs or URTIs. Odds Ratios (ORs) were
obtained from multivariate logistic regression models
to depict associations between socio-demographic fac-
tors and self-medication, use of prescribed medicines
and antibiotic use. Results with a probability level of
p < 0.05 and 95% confidence intervals (CIs) not including
the value 1 were considered as statistically significant.
Results
Characteristics of the study population stratified by gen-
der are listed in Table 1. 16.5% of all participants are liv-
ing in the former East Germany and about 17% have an
immigration background. The largest part of the boys













Rural town 1958 17.9
Small town 2337 27.6
Medium-sized town 2498 29.0









n unweighted; % weighted.
German Health Interview and Examination Survey for Children and Adolescents (KiGstatus. No significant differences are observed between
girls and boys regarding the listed socio-demographic
characteristics.
2,595 children and adolescents used 3,648 medicines
to treat a CC or URTI during the last 7 days. The vast
majority of these medicines are drugs acting on the re-
spiratory system (ATC code R00, 84.0%), followed by
homeopathic medicines (Z00, 5.0%) and anti-infectives
for systemic use (J00, 4.7%). 21% of the used medicines
are not recorded on the last 5th level of the ATC-codes
(level of the chemical substance), because participants
forgot the brand names. Therefore, only 2,887 medicines
could get analyzed on the basis of their active ingredi-
ents. The 10 most frequently used active ingredients are
shown in Figure 1.
Table 2 illustrates the prevalence rates of drug use to treat
CCs or URTIs during the last 7 days. 14.3% (95% CI 13.2%,
15.5%) of the study participants use medicines to treat a
CC or an URTI. The use of those medicines decreases with
rising age. All other socio-demographic variables (region,
immigration background and social status) show no statisti-
cally significant differences. About half of the children usingnts by gender
Girls
(95% CI) n % (95% CI)
(13.2, 13.9) 1373 13.6 (13.2, 14.0)
(20.7, 21.3) 1907 21.1 (20.8, 21.4)
(21.4, 22.1) 2004 21.8 (21.4, 22.1)
(17.0, 17.6) 1468 17.3 (17.0, 17.7)
(25.8, 27.0) 1818 26.3 (25.7, 26.9)
(12.3, 21.9) 2847 16.5 (12.3, 21.9)
(78.1, 87.7) 5723 83.5 (78.1, 87.7)
(12.6, 27.8) 1939 17.9 (12.6, 24.8)
(20.9, 35.6) 2229 27.2 (20.5, 35.1)
(22.2, 37.0) 2475 29.3 (22.4, 37.2)
(25.5, 19.0) 1927 25.6 (19.1, 33.5)
(15.4, 19.6) 1230 16.9 (14.9, 19.1)
(80.4, 84.6) 7592 83.1 (80.9, 85.1)
(26.1, 29.4) 2306 27.3 (25.9, 28.8)
(43.7, 46.8) 3890 45.7 (44.1, 47.2)
(25.2, 29.0) 2181 27.1 (25.2, 29.0)
100 8570 100
GS), 2003–2006.











Number of drugs used within the last week
Figure 1 The 10 most frequently used active ingredients to treat common colds (CCs) or upper respiratory tract infections (URTIs).
German Health Interview and Examination Survey for Children and Adolescents (KiGGS), 2003-2006.
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physician (Table 2). The proportion decreases with rising
age. Furthermore, we observed a statistically significant as-
sociation between the use of prescribed medicine and im-
migration background as well as lower socio-economic
status. The proportion of using self-medication to treat
CCs and URTIs amounts to 57.6%. This proportion in-
creases with higher age and is also higher for childrenTable 2 Prevalence rates, proportions of overall prescribed m
prescribed antibiotics to treat common colds (CCs) or upper r
Prevalence rates Proportions of prescribed
medicine
n % (95% CI) n % (95% CI)
Gender
Boys 1255 14.0 (12.7, 15.3) 655 50.3 (47.1, 53.6)
Girls 1340 14.7 (13.5, 16.1) 685 49.8 (46.1, 53.5)
Age (years)
0 - 2 610 22.0 (19.9, 24.2) 416 66.1 (61.1, 70.7)
3 - 6 855 23.0 (20.9, 25.2) 473 55.4 (51.6, 59.1)
7 - 10 520 12.3 (10.8, 14.1) 223 42.4 (37.1, 47.8)
11 - 13 303 9.7 (8.3, 11.2) 118 38.9 (33.4, 44.7)
14 - 17 307 8.2 (7.1, 9.5) 110 34.2 (27.8, 41.1)
Region
East 834 13.3 (11.6, 15.2) 439 52.6 (46.8, 58.4)
West 1761 14.5 (13.3, 15.9) 901 49.6 (46.7, 52.5)
Immigration background
Yes 352 12.0 (11.2, 14.4) 225 63.0 (57.2, 68.4)
No 2229 14.6 (13.2, 15.5) 1108 47.7 (44.9, 50.5)
Social status
Low 683 13.8 (12.8, 15.6) 408 57.6 (53.4, 61.7)
Intermediate 1151 13.9 (12.7, 15.2) 582 48.8 (45.1, 52.5)
High 712 16.0 (14.4, 17.6) 315 43.6 (39.6, 47.7)
Total 2595 14.3 (13.2, 15.5) 1340 50.1 (47.5, 52.7)
German Health Interview and Examination Survey for Children and Adolescents (KiGwithout migration background and for children from fam-
ilies with a high social status (Table 2). Among those
children and adolescents who use prescribed drugs, the
antibiotic use is 11.6% (95% CI 9.8%, 13.7%). The antibiotic
use in the descriptive analysis is significantly associated with
immigration background and older age.
Multivariate logistic regression models show that the
use of self-medication is significantly associated withedicines, proportion of self-medication and proportion of





n % (95% CI) n % (95% CI)
688 56.4 (53.1, 59.6) 69 9.5 (7.5, 12.0)
772 58.8 (55.4, 62.1) 97 13.6 (10.8, 17.0)
249 42.0 (37.1, 47.0) 32 6.1 (3.9, 9.5)
451 52.9 (48.8, 56.9) 53 11.0 (8.1, 14.7)
328 63.1 (58.6, 67.4) 29 9.8 (6.2, 15.0)
209 69.7 (63.5, 75.3) 24 18.9 (11.6, 29.1)
223 73.4 (67.3, 78.7) 28 24.8 (16.8, 35.0)
468 57.1 (52.3, 61.8) 70 15.0 (11.9, 18.6)
992 57.6 (54.8, 60.5) 96 10.9 (8.9, 13.3)
150 43.3 (38.3, 48.4) 39 18.2 (13.2, 24.5)
1305 60.2 (57.6, 62.9) 127 10.1 (8.3, 12.2)
319 48.0 (44.0, 52.1) 53 12.3 (9.4, 15.9)
669 59.7 (56.2, 63.0) 76 13.0 (10.0, 16.7)
456 64.4 (60.3, 68.4) 31 8.0 (5.3, 11.9)
1460 57.6 (55.0, 60.1) 166 11.6 (9.8, 13.7)
GS), 2003–2006.
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background (OR 1.64; 95% CI 1.28, 2.11) and high (OR
1.77; 95% CI 1.42, 2.20) or intermediate (OR 1.44; 95%
CI 1.16, 1.82) social status. In contrast, use of prescribed
medicines is significantly associated with immigration
background (OR 1.60; 95% CI 1.21, 2.11), younger age
(OR 2.27; 95% CI 1.81, 2.85) and lower socio-economic
status (OR 1.58; 95% CI 1.25, 1.99). Antibiotic use is sig-
nificantly associated with immigration background (OR
2.37; 95% CI 1.51, 3.73), female gender (OR 1.52, 95% CI
1.05, 2.18), older age (OR 1.45; 95% CI 1.01, 2.08) and
residency in former East Germany (OR 1.67; 95% CI
1.19, 2.34) (Table 3).Discussion
The present study documents a high prevalence of medi-
cine use to treat CCs or URTIs among children and ado-
lescents in Germany. About 14% of the boys and girls
use at least one of these medicines within a given week.
The most frequently used medicines are drugs acting on
the respiratory system followed by homeopathic medi-
cines and anti-infectives for systemic use. About half ofTable 3 Socio-economic characteristics associated with the
use of self-medication, prescribed medicine and antibiotics
to treat common colds (CCs) and upper respiratory tract






Boys Reference Reference Reference
Girls 1.04 (0.87, 1.25) 1.04 (0.86, 1.26) 1.52 (1.05, 2.18)
Age (years)
0-10 Reference 2.27 (1.81, 2.85) Reference
11-17 2.40 (1.87, 3.07) Reference 1.45 (1.01, 2.08)
Region
East Reference 1.23 (0.94, 1.60) 1.67 (1.19, 2.34)
West 1.14 (0.90, 1.45) Reference Reference
Immigration background
Yes Reference 1.60 (1.21, 2.11) 2.37 (1.51, 3.73)
No 1.64 (1.28, 2.11) Reference Reference
Social status
Low Reference 1.58 (1.25, 1.99) 1.57 (0.93, 2.64)
Intermediate 1.44 (1.16, 1.80) 1.55 (0.98, 2.53) 1.55 (0.87, 2.75)
High 1.77 (1.42, 2.20) Reference Reference
Odds ratios and 95% confidence intervals were obtained from multivariate
regression models 1includes WHO-ICD-10 codes J00, J01.0, J01.9, J02.0, J02.9,
J03.0, J03.9, J04.0, J06.8, J06.9, J11.1, J11.8, R05 and R07.0.
German Health Interview and Examination Survey for Children and
Adolescents (KiGGS), 2003–2006.the children with medicine use to treat CCs and URTIs
use prescribed medicine. Almost 60% of children with
CCMs use self-medication. Self-medication is associated
with higher age, no immigration background, and high
or intermediate social-status. In contrast, children of
younger age, with an immigration background, and from
families with low social-status use significantly more
often prescribed drugs. Furthermore, antibiotic use is
significantly associated with higher age, female sex,
immigration background, and residency in former East
Germany.
Data of medicine use based on treated conditions are
sparse worldwide. The Slone Survey (1999–2006), a rep-
resentative random-digit-dialing survey collecting data
on medication use among the USA population during
the last 7 days, observes a prevalence of children’ s ex-
posure to CCMs of 10.1%. The definition CCMs includes
all oral medications containing ≥ 1 antitussive, decongest-
ant, expectorant or first-generation-antihistamine [19]. In
KiGGS, expectorants are more frequently used than anti-
tussives (6.7 vs. 1%), whereas in the Slone Survey, antitus-
sives are more often used than expectorants (4.1 vs. 1.5%).
Furthermore, there are differences regarding the active in-
gredients for certain medications, such as in antitussives
and expectorants. The Slone Survey shows a high usage of
dextromethorphan in antitussives and guafenisin in expec-
torants, whereas in our study, the most frequent active
ingredients in expectorants are ambroxol, ivy leafs and acet-
ylcystein and the most often used active ingredient in anti-
tussives is clobutinol. The use of clobutinol has ceased
since the year 2007 when all medicines containing clobuti-
nol were withdrawn from the market. Data from a cohort
study in South-West England, which were collected by self-
administered questionnaires, yield exposure prevalences of
43.1% to CCMs, 5.0% to rhinologicals and 4.3% to throat
medicines in the last 12 months among children aged up to
7.5 years [20]. However, comparability of these results with
our prevalence rates (8.9% for CCMs, 5.9% for rhinologi-
cals, 1.0% for throat medicines) is limited, mainly because
of the difference in the reference periods. Longer observa-
tion periods lead to higher prevalence rates but also in-
crease susceptibility for recall-bias. Despite of a much
shorter observation period in our survey, the prevalence
rate of rhinological use is higher in our study. This implies
the probability of a higher 12 month prevalence in
Germany compared to South-West England.
In our study self-medication for treating URTI is more
common among children with higher age and among those
without immigration background. These findings corres-
pond to earlier analyses of KiGGS data looking at overall
self-medication [7]. Moreover, our results suggest that self-
medication is associated with a higher social-status. The
same results are reported by a study looking at overall self-
medication in Dutch adolescents [21]. In contrast to self-
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decreasing with higher age in our study, which is in accord-
ance with results of the SLONE survey and a cohort study
in three European countries [19,22]. Furthermore, in the
present study the use of prescribed medication to treat CCs
and URTIs is strongly associated with having an immigra-
tion background and a lower social-status. This finding is
partly in line with earlier studies. A study in Poland ob-
serves positive associations between physician consultations
and low school-leaving qualifications, as well as between
use of OTC medicines and a high household income when
treating respiratory tract infections in adults [23]. An Israeli
cross-sectional study analyzes reasons why patients with
flu-like symptoms consult a doctor. The reason “to get a
prescription” is associated with low school-leaving qualifica-
tions, low income and unemployment [24]. However,
Dutch secondary data analysis observes no association be-
tween use of prescription medicines and social-status by
adolescents for all conditions [21].
Earlier findings looking at prevalence rates for anti-
biotic use among children in Europe and in the USA
range from 31% to 38% [25-27]. However, these data
refer to patients who were visiting a physician, thus
comparability to our findings is limited. Our results sug-
gest an increasing antibiotic use with higher age and
with female sex. A previous study based on KiGGS data
shows that children of younger age are more often ex-
posed to antibiotic use compared to older children [28].
However, this study analyses the overall antibiotic use
while the present study only looks at antibiotic use for
treatment of CCs and URTIs. Our findings are probably
influenced by not having included otitis media in the
definition of URTIs, as the prevalence of otitis media is
strongly decreasing with higher age [1]. Health insurance
data on antibiotic use in Germany does not differentiate
according to age or indication [14]. Gender differences
concerning antibiotic use are already known: Data from
the National Ambulatory Medical Care Survey from 1992
in the USA indicate a significant positive association be-
tween antibiotic consumption and female sex [29]. More-
over, findings from Abbas et al. suggest higher antibiotic
use for girls compared to boys in all age groups except for
2-4-years old children [30]. Our results regarding regional
differences are in line with the results of the EVA survey
(Einflüsse auf die ärztliche Verschreibung von Antibiotika
in Deutschland) which investigates influences on prescrib-
ing patterns by physicians in Germany. This survey dem-
onstrates that physicians in the eastern part of Germany
prescribe antibiotics more frequently than in the western
part [31]. Moreover, our results suggest an association be-
tween antibiotic use for CCs and URTIs and children with
immigration background. The findings of earlier studies
investigating this association are inconsistent. Neither a
Swedish prospective cohort study nor a Norwegian surveyobserves an association between antibiotic consumption
and immigration background [32,33]. A Cyprian cross-
sectional-study finds a higher inappropriate antibiotic use
by children with immigration background [34]. Further-
more, data of an Italian cohort-study suggests a significant
higher antibiotic prescribing rate for URTIs for children
with immigration background [27]. Altiner et al. report as
a result of a qualitative study that physicians often tend to
misinterpret the patients’ demands and often feel urged by
the patients to give them an antibiotic prescription. This
pressure is especially felt in consultations with Turkish im-
migrants [35,36].
A major strength of our study is the large number of
population-representative data with a high response-rate in-
cluding non-responder-analyses and quality assurances mea-
sures. The parents or the adolescents themselves were asked
to bring the packages of the medicines used in the previous
week to the interview. In contrast to health-insurance data,
we analyze the medication actually used by children and ad-
olescents, not only prescribed and potentially never used
medicines. However, our study has some limitations. Al-
though the personal interview was conducted by a physician,
indications were only reported by the parents or adolescents
and were not validated. Because of language difficulties and
possible cultural differences in symptom reporting, this
might result in more imprecisely measured data particularly
among children with immigration background. Recall bias
has to be considered which would result in underreporting.
By limiting the observation period to 7 days prior to the
interview we tried to minimize recall bias. Because of the
cross-sectional design of the survey it is not possible to draw
conclusions on the risks children and adolescents are to ex-
posed to the used medicines. A longitudinal study is re-
quired to examine this. Furthermore, although all reported
conditions were documented and confirmed by medical pro-
fessionals, a standardized severity assessment was not carried
out. Thus, we are not able to asses if the antibiotic prescrib-
ing was unnecessary.Conclusions
In summary, our study shows that the medicine use to treat
CCs or URTIs is highly prevalent among children in
Germany. Thus, longitudinal studies should investigate po-
tential risks concerning this drug use. Furthermore, differ-
ences in socio-demographic variables, particularly sex, age,
immigration background, and the difference between West
and former East Germany, regarding antibiotic use indicate
that there could be an implausible prescribing behavior
among physicians in Germany. Thus, physicians should get
trained to follow established guidelines when prescribing
antibiotics for CCs and URTIs.
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